Use Avon Products Inc. story with your portfolios to protect against small markets fluctuations as well as to determine Stock diversification method that is right for you.
Zacks.com - Feb 16, 2012
Teva Pharmaceutical Industries' (TEVA) fourth quarter earnings of $1.59 per American Depository Share (ADS) were a penny above the Zacks Consensus Estimate and 27.2% above the year-ago earnings.
Story Momentum
This story from www.zacks.com contributed to next trading day price decline. The story delta to the next closing price was 2.24% . The story delta to the current price is 15.74% .
By Sapna Maheshwari on May 10, 2012 Avon Products Inc. (AVP) (AVP) is on the brink of losing its investment-grade ratings at Standard & Poor's and Fitch Ratings because of potential debt tied to Coty Inc.'s bid for the company and weaker-than-expected ...
Coty Raises Offer to Acquire Avon Products to $24.75 a Share - Bloomberg
Ratings Firms Take Negative Action On Avon - Wall Street Journal
Avon Products, Inc. (AVP: News ) is rising 3 percent to $22.19. The company disclosed that it has received a letter from Coty Inc. about boosting its acquisition proposal to $24.75 per share from the previous $23.25 per share offer.
Mergers and Acquisitions Recap: Bed Bath & Beyond Hearts Cost Plus ... - Wall St. Cheat Sheet
Avon Products (AVP) has high quality beauty products, a long/distinguished history and a premier reputation in direct sales. It offers its 6.4 million direct sales reps.
Todays Highlight: Options Trading Alert: Avon (NYSE:AVP) by Mumbai News - The Mumbai Times
Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
